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Kaposi's Sarcoma: An Opportunistic Neoplasm 
The recognition in mid-1981 of the unprecedented epidemic 
of a previously undescribed disseminated and fulminant form 
of Kaposi's sarcoma (KS), Pneumocystis carinii pneumonia, 
and other opportunistic infections in young homosexual men 
heralded the identification of a new disease now known as the 
acquired immune deficiency syndrome (AIDS) [1-6]. As the 
name implies, AIDS is a "secondary" immunologic disorder 
that results in profound immune suppression. For the purposes 
of epidemiologic surveillance, the Centers for Disease Control 
(CDC) have formulated a strict operational definition of AIDS: 
the finding of a number of infectious diseases or Kaposi's 
sarcoma that is "moderately indicative" of an underlying cel-
lular immunodeficiency in a patient where no cause for the 
immune defect can be found [7]. The neoplastic and infectious 
diseases that are currently being accepted by the CDC as 
criteria for the diagnosis of AIDS are included in Table L After 
more than 3 years the cause of the persistent underlying dis-
turbance of cell -mediated immunity that is the hallmark of this 
disease remains a total mystery. The current mortality rate is 
over 50% within 2 years of onset of AIDS. Seventy-one percent 
of the cases to date have occurred in men of homosexual or 
bisexual orientations. Other epidemiologic groups in the United 
States that have been identified to be at-risk for AIDS include: 
heterosexual intravenous drug users (17% of cases), Haitian 
immigrants in North America (5% of U.S. cases), hemophiliacs 
receiving lyophilized, factor VIII blood clotting concentrates 
(1% of cases), transfusion recipients of blood or blood compo-
nents up to 5 years prior to the onset of their illness (1 % of 
cases), and heterosexual contacts of persons at increased risk 
for acquiring AIDS (1 % of cases) [ 4- 7]. 
Children are subject to various congenital conditions of cel-
lular immune deficiency. These must be ruled out in considering 
the possible pediatric occurrence of AIDS. Among the condi-
tions that can cause cellular immune deficiency in infants are 
congenital diseases including infections with such pathogens 
as herpes simplex virus, cytomegalovirus, and toxoplasmosis. 
Specific illnesses that are associated with primary immune 
deficiency in children include severe combined immune defi-
ciency, DiGeorge syndrome, Wiscott-Aldrich syndrome, graft-
versus-host disease, ataxia-telangiectasia, agammaglobuline-
mia, neutropenia, and others. Secondary immune deficiency 
related to starvation, lymphoreticular malignancies, and im-
munosuppressive therapy in children suspected of having AIDS 
must be ruled out as welL Nevertheless, pediatric cases of AIDS-
like disease have been reported and are currently under evalu-
ation separately from the adult cases of AIDS [8]. Of the 42 
reported cases in children under 5 years of age all had severe 
opportunistic infections; two also had KS (69% have died)_ 
Although almost all of these infants were from "high-risk" 
households, some had received transfusions of blood or blood 
components before their onset of illness. The AIDS-like ill -
nesses observed in children may represent manifestations of 
one of the congenital diseases of immune deficiency. In the 
past such cases were perhaps among the unexplained disease 
in infants often referred to as "failure to thrive." 
Eighty-one percent of the approximately 3400 cases of AIDS 
in the United States that have been reported to the CDC came 
from large cities in New York, California, Florida, and New 
Jersey; cases have been identified in almost every state, includ-
ing the District of Columbia and Puerto Rico. To date almost 
half (45%) of the total number of cases have come from the 
New York City area (42% New York City, 3% Newark) . Pa-
tients with thi s devastating disease have also been seen in at 
least 37 other countries, suggesting that AIDS is now a world 
health problem. 
About one-third of the AIDS patients either present with or 
develop an epidemic disseminated form of Kaposi's sarcoma 
(EKS) during the course of their illness. It is striking that 95 % 
of all cases of EKS associated with AIDS has been identified 
in homosexual men. The remaining 5% has been seen in 
heterosexual drug users and Haitians. To date these include 
the nine known cases of EKS in women with AIDS. 
Epidemic Kaposi's sarcoma associated with AIDS behaves in 
an opportunistic manner similar to the broad spectrum of life-
threatening infections to which patients with AIDS are vulner-
able. Prior to t he AIDS epidemic, KS was considered a rare 
neoplasm predominantly seen in males and was known to occur 
in various but specific populations. First described in 1872, the 
classical form of KS is an uncommon localized indolent skin 
tumor usually observed in elderly men of Mediterranean or 
eastern European Ashkenazic Jewish origin. The lesions of 
classical KS usually present as singular or groups of reddish to 
purple, sometimes hyperpigmented, macules or plaques com-
monly localized to the lower extremities. The lesions often 
increase in number and enlarge to become elevated nodules . 
Although the classical disease typically runs a benign course 
up to 15 years after onset, infrequently a more virulent clinical 
course is observed with the development of multiple lesions at 
distant sites on the skin and occasionally with systemic visceral 
organ involvement [9]. About one-third of patients with the 
classical form of KS develop other tumors of lymphoid origin 
prior to or after the appearance of this disease. 
In the 1950s, KS was recognized to be one of the most 
common tumors to occur in the same region of Equatorial 
Africa where Burkitt's lymphoma is known to be endemic 
[10]. KS accounts for 3- 9% of all tumors reported in males in 
Zaire, Tanzania, and Uganda [10]. In Africa, KS appears as a 
more aggressive, locally invasive cutaneous form in young black 
adults, eventuating in visceral organ involvement. A rapidly 
fatal, generalized, lymphadenopathic variety of this disease 
occurs in prepubescent black children in whom skin lesions are 
uncommon. It is interesting to note that KS is found to be an 
uncommon tumor in whites and Asians living in the same 
regions of Africa. 
During t he 1960s an increased incidence of KS was found to 
occur in the United States and Canada in renal and other 
allograft recipients as well as other patients on long-term 
immunosuppressive therapy with corticosteroids and Azathio-
prine [11 ,12]. 
Among the iatrogenically immunosuppressed patients who 
develop KS, the neoplasm can be limited to one or more skin 
lesions but is often generalized involving multiple internal 
organs and lymph nodes. Regression of KS in some of these 
individuals has occasionally been observed when immunosup-
pressive therapy has been changed or discontinued. 
The unique clinical appearance and pathophysiologic behav-
ior of EKS associated with AIDS is distinctly different from 
the other known forms of this neoplasm. Clinically, EKS tends 
to present with t he sudden development of one or more lesions 
on t he skin and oral mucosa. They appear as asymptomatic, 
flat, faint pinkish to violet colored macules, plaques, and small 
nodules, in clusters or widely distributed, and frequently in 
symmetrical distribution along the lines of skin cleavage (Lan-
ger's lines) . They may resemble the cutaneous lesions of several 
other diseases including purpura, pityriasis rosea, and second-
ary syphilis. The incidence and clinical course of EKS as a 
manifestation of AIDS may serve as a clinical indicator of the 
severity of t he underlying disorder of cellular immune function. 
Those AIDS patients who initially present with only skin 
lesions of Kaposi's sarcoma often appear to be healthy clini-
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TABLE 1. Neoplastic and infectious diseases currently accepted by the 
Centers for Disease Control as crit eria for the diagnosis of the acquired 
immune deficiency syndrome (A IDS) 
--------- -----
Epide~ic Kapos i's sa rcoma (in ma les under 60 years of age) 
Lymphoma (cent ral nervous system) 
Pneumocystis can.nH pneumoma 
Mycobacl'erium oui.un:-int racellu lare (disseminated) 
Cryptococca l menmgit iS . . . 
Toxoplasn10s is (ence~hahtis , pneumoma) 
C ryptosporid ia l ententis .. 
C andida albicans (esophagit is) 
Cyto mega lovirus (pneumoni tis, co l ~tis , encepha litis) 
He rpes s implex (a nogemtal, pers ist mg for greater than lmont h; esoph-
a gitis; pneumoni t is) . . 
Aspergillosis (centra l ne rvous system or dissem mated) . 
Progressive mult ifoca l leukoencepha lopathy (J.C. Papovavirus) 
cally, free of s~mpto~s of system i~ ill_n~ss . T he parameters of 
cell -mediated 1mmumty In t hese mdJvJduals tend to be less 
severely depressed t han in those AIDS patients who develop 
life-threatening opportunistic in fect ions such as Pneumocystis 
carinii pneumonia, toxoplasmosis, or Mycobacterium auium-
int racellula re. In t he New York University Medical Center 
series of over 230 AIDS patients wit h EKS, 80% of t hose who 
d id not develop an opportunistic infection were still a live 36 
mont hs after disease onset. In contrast, t he occurrence of one 
or more opport unistic in fect ions in patients with EKS confers 
a poor prognosis; only 20% were a live after 36 mont hs. 
It has been suggested t hat as t he immunologic status of t he 
A IDS patient with EKS deteriorates, t he ne?plasm. becomes 
more disseminated. As t he disease progresses, mcreasmg num-
ber s of mucocutaneous lesions may cont inue to appear which 
often enlarge and develop into deep purple-bl~e plaques and 
noduLes. Occasionally EKS has been observed m lymph nodes 
a nd internaL organs in the total absence of cutaneous lesions. 
E pidemic Kaposi's sarcoma has provided an opportunity to 
study t he nature of this neoplasm and the possible roles of 
endogenous host factors such as t he immune s~ste~,. genetic 
makeup, a nd hormonal influences on t he predisp?sJtH~n an_d 
d evelopment of this disease. Simila rly, the role of_epJd~mwlogJc 
facto rs (including environment, vira l,and other bwlog1_c agents, 
c h e mica l exposure, and sexual practices) t hat potentia lly a lso 
influence t he host's suscept ibility for t he development of t his 
n eoplasm are under investi~ati?n. Ot~er t umors of lymp~ore­
t ic ular origin a re also seen w1 th mcreasm g frequency m patients 
w it h AIDS; t hey include undiffe rent iated lymphomas, espe-
c ia lly involving t he brain , and J?urki tt's- like lymphomas [13]: 
Observation and t reatment of EKS has led to t he hypot hesis 
t h at t his neoplasm does not behave like the more typically 
maligna nt forms of cancer. K aposi's sarcoma probably rep_re-
sents mult icent ric, widely disseminated bemgn tumors wh1ch 
a rise de novo from di ffe rent polyclonal opportunistic prolifer-
atio ns of vascular endothelial cells in immunocompromised, 
gen etically predisposed, suscept ible individuals (14] . Rece_nt 
immunohistochemical studies support t he vascula r endothelia l 
o rigin of this neoplasm [15]. Immunoperoxidase techniques 
h ave shown the presence in situ of both factor VIII-related 
a n t igens and HLA-DR antigen which are h!sto~hemical_mark ­
e r s thought to be characteristic of endothehal t1ssue. W1th the 
pro found depression of cell -mediated immunity ~he AIDS ~ost 
app arent ly loses t he int rinsic or inherent protective mechamsm 
of a functional immune surveillance monitoring and regulatory 
system. This loss permits t he unrecognized and uncont rolled 
development of abnormal foci of endothelial cell growth . The 
absence of an intact immune surveillance system also makes 
t h e AIDS patient susceptible to Jife-threating "opportunistic" 
in fections wi th biologic agents t hat may occasionally cause 
mild or subclinical disease in healt hy individuals. 
The typical wide distribut ion of EKS lesions primariLy in -
vo lving the skin and mucous membranes is unlike t he distri -
EDITORIALS 447 
bution pattern of metastatic lesions seen in malignancies such 
as melanomas, carcinomas, sarcomas, and other tumors of 
reticuloendothelial or igi n in which t he occurrence of single and 
multiple metastases to t he skin a re exceedingly rare. Like other 
sarcomas, t he tumors in each of t he diffe rent clinical fo rms of 
KS are t hought to be derived from either a "primordial" mes-
enchymal stem cell or from well -different iated vascular endo-
thelia l cells. Most sarcomas, even t he ra re angiosarcomas, 
which originate from vascular t issue, arise as a single localized 
tumor mass which eventua lly metastasizes t hrough t he blood 
stream or lymphatic system to viscera l organs, especially the 
lungs or liver. 
Despite t he various clinical presentations in the diffe rent 
epidemiologic populations in whom Kaposi's sarcoma has been 
seen, t he histology of t he neoplasm observed in each of these 
groups is indistinguisable. 
Histologically, t he observed infi lt ration of dermal connective 
t issue by proliferating endothelia l cells seen in t he earl iest 
clinical macular patch stage of KS is a lso characteristic of the 
normal pattern of vacularization of healt hy tissue and is often 
seen in other benign vascular tumors, such as pyogenic granu-
lomas a nd common hemangiomas. T he early histologic char-
acteristics of KS are often difficul t to differentiate from t hose 
observed in granulation t issue and stasis dermatit is . In an 
attempt to study t he genetic karyotype of the EKS t umor, we 
dissociated a large nodular skin lesion with collagenase. We 
were unable to find one single cell in mitosis among 5000 cells 
examined. 
Histopathologic findings of EKS lesions seen in t he t issues 
of viscera l organs in patients wit h disseminated disease do not 
resemble metastatic lesions observed wit h other malignant 
sarcomas or carcinomas. Microscopica lly, EKS-involved lymph 
nodes show minute, discrete, sinusoidal, and capsular foci of 
t he KS t umor accompanied by lymphoid hyperplasia, a picture 
not typical of metastatic invasion of lymph nodes observed in 
more malignant neoplasms. At postmortem examination , mul-
t ifoca l pulmonary lesions occasionally found in patients with 
EKS appear to origi nate from and be localized to t he walls of 
the bronchia l blood vessels wit hin t he bronchial septa. Occa-
sionally la rge EKS pulmonary lesions which a rise from the 
bronchia l vasculature appear to compress rather t han invade 
t he lung t issues, unlike the metastatic parenchymal pulmonary 
lesions commonly seen with other sarcomas [16] . Kaposi's 
sarcoma does not represent a typically malignant neoplasm. In 
fact, it is likely t hat thi s tumor rarely, if ever, spreads by 
metastasis. 
It is well known t hat several hypotheses have been proposed 
to explain t he observed close association of immunosuppression 
wi t h neoplasia. About 30 years ago, Burnet suggested the orig-
inaL "immune surveillance" hypothesis which postulated that 
one of t he functions of t he cell -mediated arm of t he immune 
system is to constant ly control and destroy emerging neoplasms 
by early recognit ion of the neoplastic cells as a lien [17]. T his 
oversimplifi ed concept was somewhat overshadowed during the 
past 2 decades by an increasing awareness of t he complexity of 
the immune system. T he significance of the host immune 
surveilla nce system is supported by the high incidence of EKS 
in patients wit h AIDS as well as by t he increased incidence of 
KS among renal t ransplant recipients and other patients wit h 
other diseases such as lupus erythematosus who are receiving 
immunosuppressive t herapy. The importance of t he potent ial 
role of immune suppression in t he evolut ion of neoplasia is 
furth er supported in view of t he high incidence of other lymph-
oid tumors observed in immunocompromised patients [11 - 13) . 
Immunosuppressed recipients of bone marrow and other organ 
a llografts t reated wi th an immunosuppressive drug, cyclospori n 
(an agent not known to be oncogen ic per se), have recently a lso 
been shown to develop neoplastic diseases [18]. It has a lso been 
noted t hat as compared to KS patients with limited and local-
ized disease, patients wit h more advanced widespread classical 
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KS may show evidence of impaired cell-mediated immunity as 
demonstrated by a decreased delayed hypersensitivity skin test 
response to dinitrochlorobenzene [9,10). Moreover, the lym-
phocytes from African KS patients with widespread aggressive 
disease were more likely to show diminished in vitro responses 
to autologous tumor cells than those with more benign disease. 
In addition it has been suggested that the fulminant generalized 
lymphadenopathic form of KS seen in black African children 
may reflect immune impairment. 
In the suscept ible, immunosuppressed host, certain vascular 
endot helial cells at one or more distant sites, simultaneously or 
in tandem, are transformed and proliferate into localized neo-
plastic lesions. Based on the "autocrine" hypothesis originally 
postulated and described by Sporn and Todaro [19,20] it is 
proposed that the focal "transformation" of endothelial cells 
may be mediated by the release of a specific KS tumor growth 
factor (TGF), produced and secreted by proliferating KS cells 
into the blood. Such a TGF substance might be a polypeptide 
hormone or hormone-like agent, s imilar to those described by 
Sporn and Todaro for other neoplasms. The production of an 
"autocrine" sec retion, TGF, may also be relevant to the path-
ogenesis of t he widely disseminated multifocal tumor seen in 
EKS patients as well as in other patients with disseminated 
forms of KS who have developed widespread disease. The 
"autocrine" concept is a simple model: certain "annointed" 
vascular endothelial cells may become transformed by the 
endogenous production of TGF for which they have specific 
receptors and to which they alone are capable of responding. 
The endogenous production of a TGF would serve as a constant 
stimulus for continued cell division, resulting in the develop-
ment of localized and/or distant foci of endothelia l hyperplasia 
throughout the vascular system. In view of this hypothesis it is 
interesting to note that Kaposi's sarcoma tumors are infre-
quently, if ever, observed either in the central nervous system 
or t he testes. These observations suggest that the proposed 
TGF may not cross the intact blood-brain or blood-testes 
barriers. 
The high incidence ofEKS associated with the current AIDS 
epidemic, a tragic experiment of nature, has provided medical 
sc ience with a unique opportunity to investigate and unravel 
t he mysteries of the neoplastic process. It is hoped that the 
rigo rous multidisciplinary investigations currently focused on 
this disease throughout the world will lead to the identification 
of those factors which significantly contribute to the develop-
ment and evolution of th is unusual tumor. The knowledge 
gained will improve our understanding of the roles and inter-
relationsh ip oJ the host natural defense mechanisms in con-
trolling neoplasia which should provide the necessary insights 
t hat will help medical science develop the means for the pre-
vention, control, and treatment of this and perhaps other 
neoplastic diseases. 
Alvin E. Friedman-Kien, M.D. 
New York University Medical Center 
New York, N. Y. 
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